US Executive Compensation Proxy SEC Filings — October 07, 2026

07-10-2026

FLEXIBLE SOLUTIONS INTERNATIONAL INC filed its DEF 14A proxy statement for the 2026 Annual Meeting, seeking shareholder approval to increase the stock incentive plan share reserve from 1,500,000 to 2,500,000 shares. CEO Daniel O'Brien's compensation actually paid (CAP) decreased 30% year-over-year to $1,012,400 in 2025 from $1,444,000 in 2024, while total shareholder return (TSR) improved significantly to $352.09 from $189.01. However, net income declined sharply by 74% to $786,894 from $3,038,529, presenting a mixed performance picture.

• · CEO Daniel O'Brien holds 240,000 options with $2.00 exercise price expiring Dec 31, 2028.
• · Director Robert Helina holds multiple option tranches: 5,000 at $3.61 (exp. 2026), 5,000 at $3.55 (exp. 2027), 5,000 at $2.00 (exp. 2027), 20,000 at $2.00 (exp. Jul 2029), 5,000 at $4.05 (exp. 2029).
• · Compensation Committee met only once in 2025; Audit Committee met four times.
• · John Bientjes resigned from both Compensation and Audit Committees on August 31, 2026; Dr. Thomas Files and Dr. Kim Reid were appointed as replacements respectively.
• · The company had no Named Executive Officers other than the CEO for the two years ended Dec 31, 2025.
• · The Stock Incentive Plan currently reserves 1,500,000 shares; proposal seeks to increase to 2,500,000 shares.
• · Shareholders will have a non-binding advisory vote on executive compensation (Say-on-Pay).

07-10-2026

The Clorox Company filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Shareholders, detailing corporate governance practices, board risk oversight, and executive compensation policies. The filing highlights the company's enhanced Enterprise Risk Management (ERM) program, cybersecurity risk management framework, and sustainability oversight, while also outlining the board's role in overseeing human capital management and corporate culture.

• · The Board's Governance Guidelines are reviewed annually by the NGCRC and updated to align with leading practices.
• · The Board oversees risks related to emerging technologies, including artificial intelligence, primarily through cybersecurity and technology oversight and the ERM assessment process.
• · The ERM Steering Committee consists of a cross-functional team of key executives and senior leaders.
• · In fiscal year 2026, the company streamlined its ERA process with a survey of leaders, interviews with senior leaders, and a risk prioritization workshop.
• · The company maintains a cybersecurity insurance program to reimburse covered costs, losses, and claims relating to data or security breaches.
• · The Audit Committee is responsible for oversight of compliance with legal and regulatory requirements relating to data privacy, cybersecurity, and IT risks.
• · The Board receives updates on human capital management through pulse surveys, annual employee engagement surveys, site visits, and town halls.

07-10-2026

CENTERSPACE (CSR) is seeking shareholder approval for its merger with IRT, where each CSR share will be converted into IRT common stock at a fixed exchange ratio. The merger is subject to numerous conditions, including approvals from both companies' shareholders and regulators, and must close by June 30, 2027. While the merger could create value, shareholders face risks including potential declines in IRT's stock price (which would reduce the consideration's value), management distraction, and the possibility of termination fees if the deal fails.

• · Exchange ratio is fixed and will not adjust for changes in stock prices, only for stock splits, reverse splits, combinations, subdivisions, reclassifications, and REIT dividends declared before closing.
• · CSR must pay a termination fee if it enters into a superior proposal; IRT may also pay a termination fee under certain circumstances.
• · IRT can defer closing until the tenth business day before June 30, 2027, to obtain lender consents on CSR's mortgage loans.
• · CSR shareholder approval requires affirmative vote of holders of at least a majority of outstanding shares.
• · IRT stockholder approval requires affirmative vote of at least a majority of votes cast on the issuance proposal (NYSE rule).
• · The merger is subject to receipt of tax opinions that the transaction qualifies as a reorganization under Section 368(a) of the Code and that both companies qualify as REITs.
• · The merger may be terminated if not consummated by June 30, 2027.

07-10-2026

CISO Global, Inc. filed its DEF 14A proxy statement for the year ended December 31, 2025, detailing executive compensation and equity plans. Total compensation for CEO David G. Jemmett increased 15% to $391,294, while CFO Debra L. Smith and Interim COO Kyle J. Young each received $1,218,366, a 311% increase from 2024, driven by large stock and option awards. However, Kyle J. Young resigned as Interim COO effective January 2, 2026, and forfeited his 2025 equity awards, highlighting leadership turnover.

• · CEO Jemmett's base salary increased from $250,000 to $375,000 under his employment agreement.
• · CFO Smith's base salary increased from $200,000 to $350,000, with a guaranteed $60,000 quarterly bonus and a discretionary $60,000 year-end bonus.
• · Kyle Young resigned as Interim COO effective January 2, 2026; his 2025 equity awards (500,000 options and 400,000 RSUs) were forfeited.
• · The 2023 Equity Incentive Plan was amended on October 31, 2025 and approved by stockholders on December 10, 2025, with 12,666,667 shares reserved.
• · As of December 31, 2024, accrued unpaid salaries were $34,142 for Jemmett and $53,285 each for Smith and Young; all were paid by December 31, 2025.

07-10-2026

Charlton Aria Acquisition Corp filed a definitive proxy statement (DEF 14A) on October 7, 2026, for an extraordinary general meeting to approve a business combination with KQC Quantum, Inc. (Parent) and Korea Quantum Computing Co., Ltd. The deal values the combined entity at an equity value of $80 million, with SPAC shareholders receiving shares of Parent Class A common stock. The filing also includes an extension proposal to push the business combination deadline beyond October 25, 2026, and notes that if the extension is not approved and no deal closes by that date, the SPAC will liquidate and redeem public shares. While the merger presents a path to Nasdaq listing for KQC, the SPAC faces redemption risk and a minimum net cash condition of $30 million at closing.

• · The Business Combination Agreement was entered into on October 6, 2026.
• · The Per Share Merger Consideration is expected to equal one share of Parent Class A Common Stock.
• · Earnout Shares are earned if Parent Class A Common Stock price reaches $12.50, $15.00, or $20.00 for 20 trading days within any 30 consecutive trading days during the five-year Earnout Period.
• · If the extension is not approved and no business combination closes by October 25, 2026, the SPAC will redeem public shares and liquidate.
• · Sponsor, officers, directors, and initial shareholders have agreed not to receive any monies from the Trust Account upon liquidation.
• · The filing includes a condition that the Registration Statement on Form S-4 be declared effective by the SEC.
• · The Business Combination Agreement contains no post-Closing indemnification obligations except for fraud or wilful breach.

07-10-2026

Onconetix, Inc. filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting to be held on November 10, 2026. The meeting will address five proposals: election of director Josh Epstein, approval of the Series F PIPE issuance, authorization of an additional reverse stock split (1-for-2 to 1-for-15), ratification of auditor MaloneBailey, and an adjournment proposal. The company has a history of reverse splits (1-for-5 in March 2026 and 1-for-10 in May 2026) and remains at risk of Nasdaq delisting if it fails to maintain compliance.

• · The company completed two transactions on July 29, 2026: issuance of Series F Preferred Stock and entry into an Equity Line of Credit, both of which could result in a large number of shares being issued.
• · The Board currently has authority to effect additional reverse stock splits through April 30, 2027, but is seeking supplemental authority for a single additional reverse split at a ratio of 1-for-2 to 1-for-15.
• · The company regained Nasdaq compliance on July 7, 2025, after a 1-for-5 reverse split, but there is no assurance of continued compliance.
• · The Series F Preferred Stock has a variable conversion price with a floor, and stockholder approval is needed under Nasdaq Rule 5635(d) because conversion could exceed 20% of outstanding common stock.
• · If the Series F PIPE Proposal is not approved, the company may be unable to honor conversions at certain adjusted prices, materially impacting future capital raising.
• · The record date for the meeting is September 29, 2026, with 5,241,486 shares of common stock outstanding and entitled to vote.

07-10-2026

SLR Investment Corp. filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on November 18, 2026. The meeting will elect two directors and ratify the selection of KPMG LLP as the independent auditor for the year ending December 31, 2026. As of the Record Date (September 24, 2026), the company had 54,554,634 shares outstanding, with interested directors Michael S. Gross and Bruce Spohler beneficially owning 7.9% and 7.2% of shares, respectively, while all executive officers and directors as a group hold 9.1%.

• · The meeting will be held virtually on November 18, 2026 at 10:00 a.m. Eastern Time.
• · Stockholders of record as of September 24, 2026 are entitled to vote.
• · Directors are elected by plurality vote; ratification of KPMG requires a majority of votes cast.
• · Thornburg Investment Management, Inc. beneficially owns 8.0% of outstanding shares.
• · Interested directors Gross and Spohler each hold shares through Solar Capital entities and a GRAT.